Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-22

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Lactococcus Lactis KD10 Powder for Improving Autism Spectrum Symptoms in Children With Autism Spectrum Symptoms. [NA]

View source ↗

Summary

A completed clinical trial evaluating the efficacy and safety of Lactococcus lactis KD10 powder for improving autism spectrum symptoms in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactococcus Lactis KD10 Powder (Lactococcus lactis KD10 powder)

Snippet

Sponsor: Miae Oh | Conditions: Autism Spectrum Disorder | NA | Status: COMPLETED